Gadofosveset trisodium Pregnancy and Breastfeeding Warnings
Brand names: Ablavar, Vasovist
Gadofosveset trisodium Pregnancy Warnings
Gadofosveset trisodium has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of teratogenicity. There are no controlled data in human pregnancy. Gadofosveset trisodium is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.
Gadofosveset trisodium Breastfeeding Warnings
There are no data on the excretion of gadofosveset trisodium into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering gadofosveset trisodium to nursing women.
See also
References for pregnancy information
- Product Information. Vasovist (gadofosveset trisodium). Bayer Pharmaceutical Inc. 2009.
References for breastfeeding information
- Product Information. Vasovist (gadofosveset trisodium). Bayer Pharmaceutical Inc. 2009.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
